» Authors » Teerha Piratvisuth

Teerha Piratvisuth

Explore the profile of Teerha Piratvisuth including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 106
Citations 3489
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Uman N, Kaewdech A, Sripongpun P, Chamroonkul N, Piratvisuth T
Gastroenterol Rep (Oxf) . 2025 Feb; 13:goaf013. PMID: 39944164
Steatotic liver disease (SLD) is an emerging liver disease, whereas chronic viral hepatitis is the renowned cause of chronic liver disease leading to cirrhosis and hepatocellular carcinoma (HCC). The impact...
2.
Hou J, Berg T, Vogel A, Piratvisuth T, Trojan J, De Toni E, et al.
JHEP Rep . 2025 Feb; 7(2):101263. PMID: 39897614
Background & Aims: We compared the clinical performance of the novel GAAD (gender [biological sex], age, alpha-fetoprotein [AFP], des-gamma carboxyprothrombin [DCP]) and GALAD (gender [biological sex], age, AFP, agglutinin-reactive AFP...
3.
Kaewdech A, Charatcharoenwitthaya P, Piratvisuth T
Viruses . 2025 Jan; 17(1. PMID: 39861823
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections remain significant public health challenges in Asia, affecting millions and contributing to substantial morbidity and mortality. The prevalence of these...
4.
Wu D, Kao J, Piratvisuth T, Wang X, Kennedy P, Otsuka M, et al.
Clin Mol Hepatol . 2025 Jan; PMID: 39838828
As new evidence emerges, treatment strategies toward the functional cure of chronic hepatitis B are evolving. In 2019, a panel of national hepatologists published a Consensus Statement on the functional...
5.
Danpanichkul P, Suparan K, Sukphutanan B, Kaeosri C, Tothanarungroj P, Sirimangklanurak S, et al.
Sci Rep . 2024 Aug; 14(1):19544. PMID: 39174722
Primary liver cancer is the third leading cause of cancer-related mortality. The increasing prevalence of metabolic syndrome and alcohol consumption, along with the existing burden of viral hepatitis, could significantly...
6.
Chaiwiriyawong S, Assawasuwannakit S, Feuangwattana P, Sripongpun P, Chamroonkul N, Piratvisuth T, et al.
Diagnostics (Basel) . 2024 Jul; 14(13). PMID: 39001216
This study aimed to evaluate the efficacy of the aMAP score and compare it with other risk scores for predicting hepatocellular carcinoma (HCC) development in Thai patients with chronic hepatitis...
7.
Kohler B, Bes M, Chan H, Esteban J, Piratvisuth T, Sukeepaisarnjaroen W, et al.
Int J Biol Markers . 2024 Mar; 39(2):107-117. PMID: 38549363
Introduction: Diagnosis of cholangiocarcinoma (CCA) can be challenging due to unclear imaging criteria and difficulty obtaining adequate tissue biopsy. Although serum cancer antigen 19-9 and carcinoembryonic antigen have been proposed...
8.
Piratvisuth T, Hou J, Tanwandee T, Berg T, Vogel A, Trojan J, et al.
Hepatol Commun . 2023 Nov; 7(11). PMID: 37938100
Background: Alpha-fetoprotein (AFP) and des-gamma carboxyprothrombin (DCP), also known as protein induced by vitamin K absence-II (PIVKA-II [DCP]) are biomarkers for HCC with limited diagnostic value when used in isolation....
9.
Kohansal-Nodehi M, Lange M, Kroeniger K, Rolny V, Tabares G, Piratvisuth T, et al.
Front Oncol . 2023 Nov; 13:1213898. PMID: 37920152
Background: There is a need for new serum biomarkers for early detection of hepatocellular carcinoma (HCC). Haptoglobin (Hp) N-glycosylation is altered in HCC, but the diagnostic value of site-specific Hp...
10.
Sonneveld M, Chiu S, Park J, Brakenhoff S, Kaewdech A, Seto W, et al.
Gastroenterology . 2023 Sep; 166(1):168-177.e8. PMID: 37769952
Background & Aims: Patients who discontinue nucleo(s)tide analogue therapy are at risk of viral rebound and severe hepatitis flares, necessitating intensive off-treatment follow-up. Methods: We studied the association between hepatitis...